Skip to content. | Skip to navigation

Garvan Institute

 
Sections
 

About Us

 

Professor Andrew Biankin Related News

 

CINSW presents Premier’s Awards to two Garvan Researchers

MEDIA RELEASE: 15 Jul 2011
At a gala dinner held last night, the Cancer Institute NSW presented Dr Alex Swarbrick with the CINSW 2011 Premier’s Fellow of the Year Award and Dr David Chang with the CINSW 2011 Premier’s Scholar of the Year Award, as well as a Pfizer Oncology International Studentship.
 
 

Helping pancreatic cancer surgeons make tiebreaker decisions

MEDIA RELEASE: 15 Apr 2011
Garvan researchers have identified two ‘biomarkers’ that appear to have the ability to predict patient survival after surgery for pancreatic cancer before the operation takes place. It is the first predictive tool of its kind for this most deadly of cancers. The American Society of Clinical Oncology (ASCO) highlights the finding in its current newsletter (ASCO Post) – distributed globally to a broad audience of cancer professionals.
 
 

Personalised medicine for cancer patients in a new technology era

MEDIA RELEASE: 15 Apr 2010
Published online today in Nature, a paper authored by over 200 members of the International Cancer Genome Consortium (ICGC) describes the beginnings of a Brave New World, a new era of personalised medicine for cancer patients.
 
 

Emily Colvin wins Premier’s Award for Outstanding Cancer Research Scholar

26 May 2009
Garvan PhD student Emily Colvin has received the prestigious $10,000 Premier's Award for Outstanding Cancer Research Scholar from the Cancer Institute NSW for her research into pancreatic cancer. The news was announced at a gala ceremony late last week.
 
 

Garvan to play a role in International Cancer Genome Consortium

MEDIA RELEASE: 26 Mar 2009
Garvan scientists will play an integral role in Australia’s contribution towards the International Cancer Genome Consortium, the details of which were announced today by Minister for Health and Ageing, The Hon. Nicola Roxon MP. They will be part of a team tackling pancreatic cancer, one of the deadliest cancers.
 
 

New prostate cancer marker helps identify men whose cancer is likely to spread

05 Oct 2006
Prostate cancer researchers at Sydney’s Garvan Institute found a new marker for identifying aggressive prostate cancers.
 
 

2005 Young Investigator of the Year

01 Jul 2006
Dr Andrew Biankin, Head of Pancreatic Cancer Research, is the recipient of the highly acclaimed 2005 Cure Cancer National Young Researcher of the Year award.
 
 

Personal tools